Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M203,546Revenue (TTM) $M52,825Net Margin (%)13.7Altman Z-Score2.2
Enterprise Value $M228,102EPS (TTM) $1.2Operating Margin %26.0Piotroski F-Score6
P/E(ttm)29.2Beneish M-Score-2.6Pre-tax Margin (%)15.8Higher ROA y-yY
Price/Book3.510-y EBITDA Growth Rate %1.8Quick Ratio1.0Cash flow > EarningsY
Price/Sales4.05-y EBITDA Growth Rate %-3.1Current Ratio1.3Lower Leverage y-yN
Price/Free Cash Flow15.1y-y EBITDA Growth Rate %1.4ROA % (ttm)4.2Higher Current Ratio y-yN
Dividend Yield %3.6PEG--ROE % (ttm)11.5Less Shares Outstanding y-yY
Payout Ratio %103Shares Outstanding M5,955ROIC % (ttm)14.2Gross Margin Increase y-yN

Gurus Latest Trades with PFE

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

PFE is held by these investors:



PFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
JOHNSON RADY AExecutive Vice President 2017-03-10Sell4,500$34.19-0.03view
HILL CHARLES HExecutive Vice President 2017-03-09Sell36,000$34.070.32view
LANKLER DOUGLAS MExecutive Vice President 2017-03-02Sell20,000$34.66-1.38view
Dolsten MikaelPresident R&D 2017-03-02Sell30,970$34.51-0.96view
Dolsten MikaelPresident R&D 2017-02-27Sell58,846$34.26-0.23view
MADDALUNA ANTHONY JExecutive Vice President 2016-11-09Sell10,000$333.58view
BOURLA ALBERTGroup President 2016-11-04Sell18,390$30.0513.74view
DAMELIO FRANK AExecutive Vice President 2016-05-26Sell100,000$34.49-0.9view
CANGIALOSI LORETTA VSr. Vice President, Controller 2016-05-24Sell86,000$33.970.62view
OLSON LAURIE JExecutive Vice President 2016-05-11Sell4,700$33.52.03view

Press Releases about PFE :

Quarterly/Annual Reports about PFE:

    News about PFE:

    Articles On GuruFocus.com
    Large-Cap Stocks Mostly Lower With Health Care Vote Uncertainty Mar 24 2017 
    US Market Indexes Lower With Losses Led by Energy Stocks Mar 23 2017 
    Companies Aiming for the Billion-Dollar Opioid Addiction Market Mar 18 2017 
    Valeant: It's Not a Game of Chess Part I Mar 16 2017 
    US Indexes Lower on Energy Stock Losses Mar 08 2017 
    America’s War on Drugs Mar 07 2017 
    Health Care Dividend Stock Showdown Mar 03 2017 
    Pfizer Reports Top-Line Results For Rheumatoid Arthritis Treatment Study Feb 27 2017 
    Dow Jones Leads Market Gains on Thursday Feb 23 2017 
    Why 3D Printing and Biotech Will Be Good Bets in 2017 Feb 23 2017 

    More From Other Websites
    Can Pfizer Boost Its Value By $5 Billion By Taking Over Bristol? Mar 27 2017
    A.M. Best Affirms Credit Ratings of Blue Whale Re Ltd. Mar 27 2017
    A.M. Best Affirms Credit Ratings of Blue Whale Re Ltd. Mar 27 2017
    Pfizer Stock Rises on Bristol-Myers Takeover Talk Mar 27 2017
    Pfizer Rheumatoid Arthritis Drug Approved in EU Mar 27 2017
    Bristol-Myers: Maybe a Pfizer Acquisition Could Makes Sense After All? Mar 27 2017
    5:04 am Pfizer receives Marketing Authorisation in the EU for XELJANZ Mar 27 2017
    XELJANZ® (tofacitinib citrate) Receives Marketing Authorisation in the European Union for the... Mar 27 2017
    XELJANZ® (tofacitinib citrate) Receives Marketing Authorisation in the European Union for the... Mar 27 2017
    Large-Cap Stocks Mostly Lower With Health Care Vote Uncertainty Mar 24 2017
    Trump, Ryan Spike Health Care Vote in Setback for President, GOP Mar 24 2017
    Novartis’s Valuation Compared to Its Peers’ Mar 24 2017
    Healthcare: Will They or Won't They? Mar 24 2017
    Mylan Hit After Abbott Dumps Shares Mar 24 2017
    Pfizer's Immunotherapy for Skin Cancer Gets FDA Approval Mar 24 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)